Director/PDMR Shareholding

Summary by AI BETAClose X

Hena Holdings Ltd, a person closely associated with Dr. Hend El Sherbini, the Chief Executive Officer of Integrated Diagnostics Holdings plc, has notified the market of a transaction involving ordinary shares. On August 12, 2026, Hena Holdings Ltd accepted a mandatory offer for 24,043 ordinary shares at a price of USD 0.50 per share, totaling USD 12,021.50, conducted on the London Stock Exchange.

Disclaimer*

Integrated Diagnostics Holdings PLC
17 August 2026
 

17 August 2026

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

The notification set out below is provided in accordance with the requirements of the UK Market Abuse Regulation.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Hena Holdings Ltd

 

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PCA of Dr Hend El Sherbini, Chief Executive Officer

b)

 

Initial notification /Amendment

  

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Integrated Diagnostics Holdings plc

b)

 

LEI

 

 

2138007JN9NUWKKTS790

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

  

a)

 

Description of the financial instrument, type of instrument

 

Identification Code:

Ordinary shares of $0.25 each in Integrated Diagnostics Holdings plc

 

JE00BLKGSR75

b)

 

Nature of the transaction

 

 

Acceptances to mandatory offer

c)

 

Price(s) and volume(s)

 

 

 

Currency

Price(s)

 

Volume(s)

USD

0.50

24,043

  

d)

 

Aggregated information

 - Aggregated volume

 - Price

 - Total

 

Volume: 24,043

Price: USD 0.50 per share

Total: USD 12,021.50

e)

 

Date of the transaction

 

 

12 August 2026

f)

 

Place of the transaction 

 

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings